Immunology and Biotherapies

Results from Positive Phase 1 Study of NovaDigm Therapeutics' NDV-3 Vaccine ...PipelineReview.com (press release)The data demonstrate that a single dose of NDV-3 with alum adjuvant was safe, well-tolerated and induced strong antibody and T-cell...

Infectious Disease Medical Article: A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza...

DNA Immunization Platform Licensed for Antibody ProductionGenetic Engineering NewsBristol-Myers Squibb negotiated a nonexclusive license to use Vical's DNA immunization technology and Vaxfectin® adjuvant for the production of therapeutic antibodies.

TheChronicleHerald.caVaccine offers chance of beating cocaine useTheChronicleHerald.caThe vaccine combines Weill Cornell's cocaine antigen, the substance that causes an immune response in the body, with Immunovaccine's DepoVax adjuvant, the...

High Non‐Specific T Lymphocyte Response to the Adjuvanted H1N1 Vaccine in Comparison with the H1N1/H3N2/B‐Brisba...

Proactive Investors USA & CanadaSoligenix Announces Positive Phase 1B Clinical Results with RiVax™, its ...Sacramento Bee... humans than adjuvant-free RiVax™.